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Abstract 23 
Purpose: Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. One 24 
consequence of raised IOP is that ocular tissues are subjected to increased 25 
hydrostatic pressure (HP). The effect of raised HP on stress pathway signaling and 26 
retinal ganglion cell (RGC) survival in the human retina was investigated. 27 
Methods: A chamber was designed to expose cells to increased HP (constant and 28 
fluctuating). Accurate pressure control (10-100mmHg) was achieved using mass flow 29 
controllers. Human organotypic retinal cultures (HORCs) from donor eyes (<24h post 30 
mortem) were cultured in serum-free DMEM/HamF12. Increased HP was compared 31 
to simulated ischemia (oxygen glucose deprivation, OGD). Cell death and apoptosis 32 
were measured by LDH and TUNEL assays, RGC marker expression by qRT-PCR 33 
(THY-1) and RGC number by immunohistochemistry (NeuN). Activated p38 and JNK 34 
were detected by Western blot. 35 
Results: Exposure of HORCs to constant (60mmHg) or fluctuating (10-100mmHg; 1 36 
cycle/min) pressure for 24 or 48h caused no loss of structural integrity, LDH release, 37 
decrease in RGC marker expression (THY-1) or loss of RGCs compared with controls. 38 
In addition, there was no increase in TUNEL-positive NeuN-labelled cells at either 39 
time-point indicating no increase in apoptosis of RGCs. OGD increased apoptosis, 40 
reduced RGC marker expression and RGC number and caused elevated LDH release 41 
at 24h. p38 and JNK phosphorylation remained unchanged in HORCs exposed to 42 
fluctuating pressure (10-100mmHg; 1 cycle/min) for 15, 30, 60 and 90min durations, 43 
whereas OGD (3h) increased activation of p38 and JNK, remaining elevated for 90min 44 
post-OGD. 45 
Conclusions: Directly applied HP had no detectable impact on RGC survival and 46 
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stress-signalling in HORCs. Simulated ischemia, however, activated stress pathways 47 
and caused RGC death. These results show that direct HP does not cause 48 
degeneration of RGCs in the ex vivo human retina. 49 
50 
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Introduction 51 
Glaucoma is a group of optic neuropathies leading to progressive loss of visual field 52 
due to the degeneration of retinal ganglion cells (RGCs) in the inner retina and loss of 53 
their axons in the optic nerve [1]. Vision loss caused by glaucoma is irreversible. 54 
Glaucoma is the second most common cause of world blindness after cataract [2] and 55 
thus the most common cause of irreversible blindness. Raised intraocular pressure 56 
(IOP) is a major risk factor for glaucoma [1,3] and current glaucoma management is 57 
aimed at reducing IOP to limit neuronal damage. IOP above the normal range of 11 to 58 
21mmHg has been shown to increase the likelihood of developing glaucoma with 59 
higher pressures leading to a progressive worsening of vision [4-7]. Fundamental 60 
questions remain, however, as to the mechanism by which elevated IOP causes 61 
degeneration of the RGCs and subsequent loss of vision in glaucoma [8]. 62 
 63 
It has proven difficult to isolate the contribution of individual variables that are affected 64 
in the eye as a result of increased IOP, which may subsequently lead to RGC death. 65 
One direct component affected by raised IOP is an increase in hydrostatic pressure 66 
(HP): when IOP increases in the eye, the retina will experience an increase in HP, 67 
acting transversely across the retina. In vitro studies, modelling this increase, have 68 
suggested exposing RGCs to raised HP may have a direct effect on survival [9-12], 69 
further suggesting that HP has a role in RGC death in glaucoma. Changes in cell 70 
survival have been detected in isolated RGCs exposed to short term pressure 71 
elevations of 50-70 mmHg [9,10,13]. Effects of HP elevations have not been 72 
investigated using human in vitro retinal models. The aim of the present study was to 73 
identify whether increased HP had a direct effect on cell survival in human RGCs. To 74 
achieve this aim a pressure chamber was designed and constructed and the effect of 75 
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raised HP was investigated using human organotypic retinal culture (HORC) used to 76 
model retinal disease in our lab [14,15]. The chamber was designed to limit possible 77 
confounding factors such as mechanical distortion of the tissue or fluid currents. The 78 
use of explant cultures permits examination in a directly ex vivo situation in which 79 
retinal cells maintain microarchitecture and cell-to-cell communication. Additionally, 80 
signalling pathways associated with stress were investigated in response to increased 81 
HP. 82 
 83 
  84 
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Materials and Methods 85 
Human Organotypic Retinal Cultures (HORCs) 86 
Donor human eyes were obtained from the East Anglian Eye Bank with ethical 87 
approval (Ref 04/Q0102/57; NHS Research Ethics Committee), with written consent 88 
from the donors’ next-of-kin and in compliance with the tenets of the Declaration of 89 
Helsinki. Retinal dissection and HORC preparation was performed as described 90 
previously [14]. Briefly, the retina was separated from the globe and dissected to give 91 
a flat retinal preparation. Five para-macular retinal explants were taken from each 92 
donor eye using a 4mm diameter, dissecting trephine (Biomedical Research 93 
Instruments, MD, USA). HORC explants were transferred to serum-free (SF) 94 
Dulbecco’s Modified Eagle Medium (DMEM)/HamF12 (Invitrogen, Paisley, UK) 95 
containing 50µg/ml gentamicin (Sigma-Aldrich, Poole, UK) in a 35mm culture dish 96 
(Corning, NY, USA). Individual HORCs were transferred to separate culture dishes 97 
containing fresh medium and incubated for 1h in a humidified atmosphere of 95% 98 
Air/5% CO2 prior to experimentation. Throughout the experimental period, the explants 99 
were contained in 35mm dishes containing 1.5ml SF DMEM/HamF12. The explants 100 
were submerged in the medium, but not in contact with the base of the dish. Only eyes 101 
within 24h post mortem were used for research and those with known/evident retinal 102 
disease such as glaucoma, age-related macular degeneration or diabetic retinopathy 103 
were excluded. In total 68 human eyes, from donors aged 43 to 84 years, were used 104 
in the experiments. 105 
 106 
Pressure System 107 
A custom-made chamber was constructed (UEA mechanical workshop, Norwich, UK) 108 
from Perspex to expose tissue explants to increased HP (Fig. 1A). Chamber internal 109 
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dimensions were 260mm x 130mm x 140mm giving an overall volume within the 110 
chamber of 4732ml. A Perspex door was used to seal the chamber against a 111 
continuous rubber O-ring. Explants were placed inside the chamber on a raised 112 
platform in 35mm culture dishes. The dishes had lids, which were loosely fitted 113 
allowing gas exchange and equilibration of pressure. The base of the chamber was 114 
flooded with sterile deionised water in order to maintain humidity.  115 
 116 
The chamber used mass flow controllers (MFCs), positioned at the inlet and outlet 117 
ports, to simultaneously regulate the internal pressure and the rate of gas flow through 118 
the chamber. Pressurised gas (95% air/ 5% CO2) could be rapidly injected into the 119 
chamber using a 1000ml/min MFC and released via a solenoid exhaust valve. Custom 120 
written software regulated internal pressure based on levels measured by a digital 121 
pressure sensor (Omega Engineering Inc, Manchester, UK). The software was able 122 
to control gas flow via an analogue to digital interface which operated the MFC and 123 
exhaust valve (Fig. 1B). The time required for compression between 10 and 100mmHg 124 
was approximately 30 seconds. The chamber regulated to ±1mmHg around the 125 
selected set-point (therefore at “constant” 60mmHg, the pressure varied between 59 126 
and 61mmHg).  Fig. 1B shows a constant pressure trace (HP(C); 60mmHg for 24h); 127 
Fig. 1C shows a fluctuating pressure trace (HP(F): 10-100mmHg; 1 cycle/min for 60 128 
min). A second low capacity (100ml/min) MFC positioned on the outflow ensured a 129 
constant flow of gas through the chamber at 10ml/min that was independent of 130 
pressure. In order to give an analogue readout, a manometer was also fitted to the 131 
chamber. No compensation for changes in atmospheric pressure were made: the 132 
raised HP in the chamber was in addition to atmospheric pressure. Controls were 133 
maintained at atmospheric pressure in the same incubator. 134 
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 135 
No significant changes in pH or evaporation rate were detected between control and 136 
medium exposed to pressure for the experimental period (data not shown). pH was 137 
measured following removal of the medium from the chamber using a glass electrode 138 
(ThermoScientific, Loughborough, UK). Evaporation was assessed by weighing the 139 
medium before and after exposure to experimental conditions. 140 
 141 
Measurement of dissolved oxygen concentration 142 
O2 concentration in distilled water or culture medium exposed to pressure was 143 
measured using a Hansatech DW1 Oxygen Electrode (Hansatech Instruments Ltd, 144 
Norfolk, UK). The system was calibrated before each use with air saturated water or 145 
medium and oxygen-free water or medium (bubbled with 95% N2, 5% CO2 for 10min). 146 
35mm culture dishes containing 1.5ml solution were exposed to various pressures or 147 
control conditions for 30min. 1ml of treated solution was then placed in the oxygen 148 
electrode reaction vessel. Oxygen concentrations were measured every second for 149 
~1min whilst constantly stirring at 450rpm. The mean values for each oxygen 150 
concentration measurement were recorded (nmol/ml). The effect of pressure on O2 151 
concentration in our pressure system closely followed that predicted by Henry’s Law 152 
[16] where the amount of a given gas that dissolves in a liquid is directly proportional 153 
to the partial pressure of that gas in equilibrium with the liquid (Fig. 2). The deviation 154 
from Henry’s Law likely reflects oxygen loss in the time taken between sampling and 155 
measurement. Correlation between predicted and measured O2 concentration further 156 
validates that the pressure in the chamber was at the designated set pressure. 157 
 158 
Simulated ischemia 159 
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HORCs were exposed to oxygen glucose deprivation (OGD) as described previously 160 
[14]. Briefly, 1h following dissection, the medium was changed to glucose-free DMEM. 161 
Explants were then placed in a modular incubator chamber (Billups-Rothenburg, CA, 162 
USA) gassed with 95% N2/5% CO2 and placed in an incubator at 35°C for 3h. Control 163 
cultures underwent the same number of medium changes except using DMEM 164 
(containing glucose) and were incubated at atmospheric conditions in the same 165 
incubator as the modular chamber. Samples were directly processed, or medium was 166 
exchanged for SF DMEM/HamF12 (containing glucose) until the experimental end 167 
point. 168 
 169 
Lactate dehydrogenase (LDH) assay 170 
The level of cell death was determined by measuring the LDH activity in cell culture 171 
medium according to the manufacturer’s instructions (Roche Molecular Biochemicals, 172 
Burgess Hill, UK).  173 
 174 
Quantitative Real Time PCR (qRT-PCR) 175 
Total RNA was extracted from HORCs using the RNeasy Mini Kit (Qiagen, Crawley, 176 
UK) according to the manufacturer’s instructions. The concentration of total RNA was 177 
measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 178 
Wilmington, USA). Total RNA was reverse transcribed to complementary DNA (cDNA) 179 
in a reaction mix of Superscript II reverse transcriptase (Invitrogen, Paisley, UK), dNTP 180 
mix (Bioline, London, UK) and random primers (Promega, Southampton, UK) 181 
according to manufacturer instructions.  182 
 183 
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TaqMan PCR was performed using 5ng of input cDNA and Taqman PCR mastermix 184 
(Applied Biosystems, Warrington, UK) and human THY-1 primer and probe set 185 
(Hs00174816_m1, Assay on demand, Applied Biosystems, Warrington, UK). 186 
Amplification and detection was performed using the ABI Prism 7700 Sequence 187 
Detection System (Applied Biosystems, Warrington, UK). THY-1 mRNA was 188 
normalised to the geometric mean of CT values for cytochrome c-1 (CYC-1) and 189 
topoisomerase DNA I (TOP1) as described previously [14]. Normalising genes were 190 
selected from a range of housekeeping genes using the Genorm protocol [17]. 191 
 192 
Immunohistochemistry and TUNEL-labelling 193 
Immunohistochemistry and TUNEL-labelling were used to assess the number of 194 
surviving RGCs in HORCs as described previously [14]. Briefly, HORCs were fixed in 195 
4% formaldehyde for 24h and then cryopreserved in a 30% sucrose solution in PBS 196 
for a further 24h at 4°C. HORCs were mounted in Optimal Cutting Temperature 197 
compound (OCT) (Sakura Finetek, Zoeterwoude, Netherlands) and frozen at -80°C. 198 
13µm retinal slices were taken using a Bright OTF 5000 cryostat (Bright Instruments, 199 
Huntingdon, UK) and mounted on 3’aminopropyl-triethoxyl silane (TESPA; Sigma-200 
Aldrich, Poole, UK) coated glass slides. Assessment via Digital Vernier Caliper 201 
(Clarke, Essex, UK) ensured slices were taken at the centre of 4mm samples. 202 
 203 
The primary antibody used was mouse monoclonal NeuN (1:200) (Chemicon 204 
International, Millipore, Watford, UK) and the secondary antibody was goat anti-mouse 205 
AlexaFluor 488 or 555 (1:1000) (Invitrogen, Paisley, UK). For the TUNEL assay 206 
(Promega, Southampton, UK), retinal slices were washed and immersed in TUNEL 207 
equilibration buffer for 10min, 18h after primary antibody binding. Slices were 208 
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incubated in TUNEL reaction mixture for 1h at 35°C before stopping the reaction by 209 
immersion in standard citrate solution (SCS). After further washing, nuclei were 210 
stained with DAPI (1:100; Sigma-Aldrich, Poole, UK). 211 
 212 
18 x 200µm sections from each HORC were counted in a masked fashion. The number 213 
of NeuN-labelled cells co-localising with DAPI were used as a measure of RGC 214 
number. NeuN positive cells which also stained positive for TUNEL were identified as 215 
apoptotic RGCs. It is important to note that there is no major staining of NeuN in the 216 
inner nuclear layer suggesting that NeuN does not label amacrine cells [14]. 217 
 218 
Western blotting 219 
Protein lysates were obtained from HORCs using Mammalian Protein Extract Reagent 220 
M-PER supplemented with Halt Phosphatase Inhibitor Cocktail, Protease Inhibitor 221 
Cocktail and 5mM EDTA (All from Thermo Scientific, Loughborough, UK) for 20min on 222 
ice followed by centrifugation at 13,000rpm for 5min. Protein concentration of each 223 
lysate was determined using a bicinchoninic acid (BCA) protein assay (Thermo 224 
Scientific, Loughborough, UK). Equal amounts of protein were loaded onto 10% SDS-225 
PAGE gels and proteins separated by electrophoresis. Proteins were transferred to 226 
PVDF membrane (Perkin Elmer Life Sciences, Cambridge, UK) using a semi-dry 227 
transfer blotter (Bio-Rad Laboratories, Hemel Hempstead, UK). Membranes were 228 
blocked with PBS-T (0.1% Tween®-20 in PBS, 5% fat-reduced milk), hybridized with 229 
primary antibody followed by incubation with secondary antibody (GE Healthcare, 230 
Buckinghamshire, UK). Bands were visualised using chemiluminescent ECL Plus 231 
Western Blot Detection reagent (GE Healthcare, Buckinghamshire, UK) and net band 232 
intensity determined (1D 3.5 software, Eastman Kodak, Rochester, NY). Primary 233 
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antibodies (Cell Signaling Technology, Danvers, MA, USA) against phospho- and total 234 
p38, phospho- and total JNK were used at 1:250, 1:1000, 1:500 and 1:500 235 
respectively. 236 
 237 
Statistical Analysis 238 
Data shown is the mean ± standard error of the mean (S.E.M). Significance was 239 
determined using an unpaired Student’s t-test (GraphPad Prism version 6.0, San 240 
Diego, USA).  Differences were considered significant at the p≤0.05 level. Groups 241 
were considered statistically similar if p≥0.2 (β=0.2) and p values are given throughout. 242 
Due to having only one chamber, pressure experiments were carried out 243 
independently using separate donors with appropriate same donor controls. 244 
  245 
13 
 
Results 246 
 247 
Effect of increased hydrostatic pressure on RGC survival in HORCs 248 
There was no significant increase in released LDH as a result of either constant or 249 
fluctuating pressure at 24h (HP(C) 60mmHg - n=20, p=0.564; HP(F) 10-100mmHg 1 250 
cycle/min - n=8, p=0.794)  or 48h (HP(C) 60mmHg - n=20, p=0.907; HP(F) 10-251 
100mmHg - n=8, p=0.838) compared with controls (Fig. 3A). As a positive control, 252 
simulated ischemia caused an approximate 50% increase in release of LDH into the 253 
culture medium at 24h, indicating that increased death of retinal cells had occurred 254 
under these conditions (n=11, p=0.0001; Fig. 3A). Retinal architecture was preserved 255 
in HORCs exposed to constant and fluctuating HP for 24 or 48h and OGD for 24h, 256 
with no observed differences between control and pressure groups or with simulated 257 
ischemia (Fig. 3B, C & D). 258 
 259 
Focussing more specifically on survival of RGCs in HORCs, NeuN labelling and THY-260 
1 mRNA expression were quantified (Fig. 4A&B). The numbers of NeuN-labelled 261 
neurons relative to controls did not change after exposure to either constant or 262 
fluctuating pressure for 24h (HP(C) 60mmHg – n=9, p=0.947; HP(F) 10-100mmHg – 263 
n=10, p=0.955) or 48h (HP(C) 60mmHg – n=9, p=0.668; HP(F) 10-100mmHg – n=10, 264 
p=0.733) (Fig. 4A). In addition, no significant change in the level of THY-1 mRNA 265 
between control and pressure exposure at either time-point was observed with either 266 
pressure regime (HP(C) 60mmHg 24h – n=4, p=0.878; HP(C)  60mmHg 48h – n=4, 267 
p=0.837; HP(F) 10-100mmHg 24h – n=4, p=0.584; HP(F) 10-100mmHg 48h – n=4; 268 
p=0.516) (Fig. 4B). Simulated ischemia, however, caused an almost 50% reduction in 269 
the number of NeuN-labelled cells compared with controls (n=9; p=0.021; Fig. 4A) and 270 
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a similar decrease in THY-1 mRNA levels (n=8; p=0.010; Fig. 4B), indicating a 271 
reduction in RGC number. 272 
 273 
Since it might be expected that decline in RGC number could occur later than 48h, but 274 
that apoptosis may have been initiated during this period, the number of TUNEL-275 
positive NeuN-labelled cells was also assessed (Fig. 4C-G). No significant differences 276 
in the number of apoptotic RGCs were observed at either time-point using either 277 
pressure regime (HP(C) 60mmHg 24h – n=4, p=0.531; HP(C) 60mmHg 48h – n=4, 278 
p=0.349; HP(F) 10-100mmHg 24h – n=4, p=0.695; HP(F) 10-100mmHg 48h – n=4; 279 
p=0.853). OGD, on the other hand, caused an approximate doubling of the number of 280 
TUNEL-positive NeuN-positive cells at 24h (n=4; p=0.011) indicating that it was 281 
inducing significant apoptotic cell death by this time-point (Fig. 4G). 282 
 283 
Effect of hydrostatic pressure on p38 and JNK signalling 284 
Investigation of the stress pathways p38 and JNK showed no increased activation 285 
(phosphorylation) in HORCs following exposure to fluctuating pressure (10-100mmHg; 286 
1 cycle/min) at 15 min (n=3; p38 p=0.769; JNK p=0.354), 30 min (n=3; p38 p=0.696; 287 
JNK p=0.667), 60 min (n=3; p38 p=0.232; JNK p=0.891) and 90min (n=3; p38 288 
p=0.0.273; JNK p=0.833) (Fig. 5A, B). HORCs exposed to simulated ischemia, 289 
however, showed a sustained increase in p38 and JNK phosphorylation compared to 290 
controls, with significant increases at the end of the OGD period (0 min; n=3; p38 291 
p=0.012; JNK p=0.006), at 60 min (n=3; p38 p=0.019; JNK p=0.039) and 90 min (n=3; 292 
JNK p=0.049) post-OGD. Activation was therefore observed directly following the 3h 293 
OGD period and activation remained elevated at subsequent time points for 90min 294 
post-insult (Fig. 5C, D).   295 
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Discussion 296 
Although ocular hypertension has been identified as a major risk factor for glaucoma, 297 
precisely how raised IOP translates into loss of RGCs and consequent visual field 298 
deterioration is poorly understood. Several previous studies have suggested that 299 
increased HP can induce RGC death [9-12]. The aim of the present study was 300 
therefore to investigate whether similar pressure-induced loss of retinal cells could 301 
also be observed in the human retina using an explant (HORC) model. 302 
 303 
Since we were using a custom-made pressure chamber, it was important to validate 304 
the system and consider any potential confounding factors. By using MFCs it was 305 
shown that HP could be accurately increased within the chamber and also be tightly 306 
regulated. Pressure increased to the target pressure within 30sec and was maintained 307 
within ±1mmHg. Using this system, we could be confident that no uncontrolled initial 308 
pressure surges were experienced by the tissue, such as could occur if the chamber 309 
were connected directly to a gas cylinder. Also using this system we could be confident 310 
that there was no movement of the tissue, either via fluid turbulence or movement of 311 
the underlying substrate. We were, in turn, confident that the tissue was exposed 312 
purely to raised HP and that we had not inadvertently introduced any mechanical 313 
distortion. We measured evaporation of medium from dishes in the chamber and found 314 
no difference at raised HPs compared to control dishes outside of the chamber, such 315 
that one would not anticipate any exposure to differing osmotic conditions. In addition, 316 
in design of the system we enabled a constant gas flow through the chamber, 317 
independent of pressure regulation, in order to mitigate against changes in gas 318 
composition (albeit very small due to the large volume of this chamber) as a result of 319 
tissue respiration. It does, however, have to be addressed, that some changes could 320 
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not be mitigated against when using this design of chamber. Specifically, in chambers 321 
that increase HP by raising the gas pressure at a gas-liquid interface, the 322 
concentration of dissolved gases in the medium must be considered. Increasing 323 
pressure in the gas phase increases the partial pressure of each gas within this phase; 324 
this leads to a proportional increase in the concentration of dissolved gases, including 325 
O2, in the liquid phase (ie. the medium) as described by Henry’s Law. An increase in 326 
O2 was measured in the medium within our chamber (Fig. 2) in agreement with Henry’s 327 
Law. Therefore, any measured effects of raised HP in our system would have needed 328 
to take this increase in O2 into consideration. Raised partial pressure of CO2 would 329 
also occur, so it was also important to measure medium pH; this was not found to 330 
change significantly under the conditions of the experiment i.e. buffering of the medium 331 
was sufficient to compensate for the increased [CO2]. We were confident, therefore, 332 
that apart from an increase in [O2] as a result of Henry’s Law, that we had considered 333 
and addressed other potential confounding factors such that we would be able to 334 
interpret any changes seen in cell viability in terms of an effect of HP on the retinal 335 
cells. 336 
 337 
Exposing the retinal explants to increased HP for up to 48h did not cause a reduction 338 
in RGC survival or induction of apoptosis in response to constant (60mmHg) or 339 
fluctuating pressure (10-100mmHg; 1 cycle/min). In contrast, as a positive control, we 340 
exposed HORCs to simulated ischemia which did cause significant loss of RGCs. 341 
Increased p38 and JNK phosphorylation has previously been described in animal 342 
models of glaucoma [18-21] and p38 or JNK pathway inhibition has been shown to 343 
protect RGCs following axotomy [22,23] and ischemia [18]. In HORCs exposed to 344 
increased HP, no significant change in p38 and JNK phosphorylation was detected. 345 
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HORCs subjected to simulated ischemia, however, showed increased p38 and JNK 346 
phosphorylation at early time-points, thus demonstrating the sensitivity of our model 347 
system.  348 
 349 
To our knowledge, only one previous paper has investigated the effects of HP on 350 
retinal explants [12]. The research exposed rat retinal explants to raised HP and 351 
showed a loss of RGC viability, but only when the pressure was increased very rapidly 352 
(at approximately 8mmHg/s). A slower increase of approximately 3mmHg/s did not 353 
cause loss of viability. In our experiments, the rise was commensurate with the slower 354 
rate and therefore the results could be seen as consistent with this previous data. 355 
Whether we would see loss in viability with a greater rate of increase in HP could not 356 
be tested with our system, but it should be noted that such rapid changes in IOP would 357 
not be experienced in patients with glaucoma.  358 
 359 
Other studies on the effects of raised HP have utilised isolated retinal cells, cultured 360 
on rigid, artificial substrates specifically glass and tissue culture plastic [9-11]. 361 
Although these cultures provide valuable information with regards to individual cell 362 
type responses, their usefulness as a model of the retina is limited due to lack of cell-363 
matrix and cell-cell attachments and signalling between RGCs and the supporting glia 364 
and inner retinal cells. The fact that the cells are cultured on a rigid surface would exert 365 
extra forces when HP is raised which could impact RGC survival in this experimental 366 
system. Retinal explant models more closely reflect the cell organisation and 367 
interactions within the eye and although the HORC model does not maintain 368 
associations with the RPE, its basement membrane, the choroid and the sclera, the 369 
potential effects of HP on RGCs against their natural retinal substrate, the IPL and 370 
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INL, are preserved. Neither model can therefore exactly replicate the in vivo 371 
environment of the eye. Differences between the outcomes using these experimental 372 
models could potentially be explained by these differences between the culture 373 
systems. 374 
 375 
It should be remembered that HP only constitutes a small component of forces 376 
associated with elevated IOP, specifically, the transverse stress across the retina. In 377 
the eye in vivo, pressure is acting within a closed system and there is a differential 378 
pressure between the inside and outside of the eye. It can therefore be described in 379 
mechanical terms by modelling the effects of raising pressure within a closed vessel. 380 
Within a closed vessel, pressure has two mechanical effects: it directly causes a stress 381 
transversely through a section of the vessel wall (along a radial axis), but it also creates 382 
an in-plane tensile stress in the vessel wall, which resists stretching of the 383 
circumference. The latter stress is known as “hoop stress” and acts along the surface 384 
of a vessel wall in a circumferential direction. For a pressure vessel of radius 15mm 385 
and wall thickness of 1mm, the hoop stress would be 15 times greater than the 386 
transverse stress for a given increase in internal pressure. In the eye, the hoop stress 387 
would be experienced predominantly in the tissue with the highest tensile strength, 388 
specifically, the sclera. Associated strains would in turn be experienced in the adjacent 389 
tissues also in the orthogonal direction. The consequences of hoop stress as a result 390 
of increased IOP are therefore more likely to influence RGC survival compared to the 391 
transverse stress across the retina. Importantly, hoop stress would not be modelled in 392 
an experimental system where cells or tissue were cultured in dishes that are placed 393 
within a chamber where HP is raised.  394 
 395 
19 
 
In our experiments, it was found that applying HP to retinal explants did not result in 396 
RGC death or influence pathways associated with changes in survival. We would 397 
therefore suggest that the component of raised IOP that is modelled by increasing HP, 398 
i.e. the transverse stress across the retina that increases as IOP is raised, is not a 399 
direct contributor to RGC death. Certainly our results are consistent with the 400 
compelling argument that application of HP alone is not a surrogate for IOP in 401 
glaucoma [24,25]. Investigators should therefore look more towards models that 402 
replicate strain/stress in ocular tissues as more appropriate models of the physical 403 
consequences of raised IOP. The rapidly expanding field of ocular biomechanics [26-404 
30] will be critical in this respect and it certainly would be interesting to look further at 405 
the effects of hoop stress-associated strain, which could be modelled in vitro by 406 
orthogonal stretching of the retina. Further to this, it is clear that we need to learn more 407 
about the stress/strain relationships both between the retina and its adjacent 408 
structures and within the retina: could attachments of the RGCs and their relationship 409 
to, for example, the nerve fibre layer, cause stress in this region of the retina that 410 
makes the RGCs more susceptible to increased pressure than other retinal cells? 411 
Application of research from this important field will be critical in allowing the 412 
development of pathophysiologically relevant models to measure RGC death with 413 
respect to glaucoma.  414 
  415 
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Figure Legends. 518 
Figure 1: The system used to expose retinal tissue to raised hydrostatic 519 
pressure (A) Schematic diagram of the hydrostatic pressure system (not to scale). 520 
Examples of computer controlled protocols using the pressure system at (B) constant 521 
(60mmHg) pressure for 24h and (C) fluctuating (10-100mmHg; 1 cycle/min) pressure 522 
for 1h. MFC = mass flow controller. 523 
 524 
Figure 2. Changes in dissolved O2 with increased HP above atmospheric 525 
pressure. O2 concentration in water and medium is expressed as the percentage of 526 
the concentration recorded at atmospheric pressure (n=4). The gas in the chamber 527 
was 95% air/ 5% CO2. The O2 concentration in pure water predicted by Henry’s Law 528 
is also shown. 529 
 530 
Figure 3. Elevated hydrostatic pressure (HP) did not cause necrotic cell death 531 
or loss of retinal structure in HORCs. (A) No increase in necrotic cell death, 532 
measured by released cytoplasmic LDH, was observed after constant (HP (C); 533 
60mmHg) or fluctuating (HP (F); 10-100mmHg; 1cycle/min) pressure for 24 or 48h 534 
(HP(C) 60mmHg 24h - n=20, p=0.564; HP(C) 60mmHg 48h - n=20, p=0.907; HP(F) 535 
10-100mmHg 24h - n=8, p=0.794; HP(F) 10-100mmHg 48h - n=8; p=0.838). A positive 536 
control of 3h OGD/21h control conditions led to a significant increase in released LDH 537 
compared to control conditions (n=11; *p=0.0001). (B-D) Representative 538 
immunofluorescence photomicrographs of HORCs; (B) 24h control (i) or pressure (ii, 539 
iii) exposure, (C) 48h control (i) or pressure (ii, iii) exposure and (D) 24h control (i) or 540 
3h OGD/21h control conditions (ii). DAPI = blue, NeuN = green, GCL = ganglion cell 541 
layer, INL = inner nuclear layer, ONL = outer nuclear layer. Scale = 200µm. 542 
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 543 
Figure 4. Elevated hydrostatic pressure did not decrease the expression of 544 
RGC specific markers in HORCs or cause RGC apoptosis. (A) Constant (HP(C); 545 
60mmHg) or fluctuating (HP(F) 10-100mmHg; 1cycle/min) pressure did not decrease 546 
the number of NeuN-labelled RGCs at the 24 or 48h time-points (HP(C) 60mmHg 547 
24h - n=9, p=0.947; HP(C) 60mmHg 48h - n=9, p=0.668; HP(F) 10-100mmHg 24h - 548 
n=10, p=0.955; (HP(F) 10-100mmHg 48h - n=10; p=0.733). A significant reduction in 549 
NeuN-labelled cells was observed following simulated ischemia (3h OGD/21h control 550 
conditions) (n=9; *p=0.002). (B) Elevated HP for 24 or 48h did not reduce THY-1 551 
mRNA expression compared to same time point controls (HP(C) 60mmHg 24h - n=4, 552 
p=0.878; HP(C) 60mmHg 48h - n=4, p=0.837; HP(F) 10-100mmHg 24h - n=4, 553 
p=0.584; HP(F) 10-100mmHg - n=4; p=0.516). A significant reduction in THY-1 554 
expression was caused by 3h OGD/21h control conditions (n=8; *p=0.010). (C-G) 555 
Apoptotic labelling in RGCs was low with no increase in the number of TUNEL+ 556 
NeuN-labelled cells at 24 or 48h after constant or fluctuating pressure compared to 557 
controls (HP(C) 60mmHg 24h - n=4, p=0.531; HP(C) 60mmHg 48h - n=4, p=0.349; 558 
HP(F) 10-100mmHg 24h - n=4, p=0.695; HP(F) 10-100mmHg - n=4; p=0.853). An 559 
increase in the proportion of apoptotic RGCs could be detected following 3h OGD/ 560 
21h control conditions (n=4; *p=0.011). DAPI = blue, TUNEL = red, NeuN = green, 561 
GCL = ganglion cell layer. White arrows highlight TUNEL+ NeuN-labelled cells. 562 
Scale = 200µm. 563 
 564 
Figure 5. Elevated pressure did not activate p38 or JNK stress signalling 565 
pathways. Phosphorylation of (A) p38 and (B) JNK, relative to their total expression, 566 
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did not significantly alter with fluctuating pressure in HORCs (n=3; 15 min- p38 567 
p=0.769, JNK p=0.354; 30 min - p38 p=0.696, JNK p=0.667; 60 min - p38 p=0.232, 568 
JNK p=0.891; 90min -p38 p=0.273, JNK p=0.833). Phosphorylation of (C) p38 and 569 
(D) JNK was observed immediately following 3h OGD (n=3; 0 min - p38 p=0.012, 570 
JNK p=0.006), and in the during the following reperfusion period in control medium 571 
(n=3; 60 min - p38 p=0.019, JNK p=0.039; 90 min - JNK p=0.049). Results are 572 
expressed as a percentage of the untreated control. Representative blots are shown. 573 
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